Can I read Promoting access to COVID-19 convalescent plasma in low- and middle-income countries on EtoBox?

Promoting access to COVID-19 convalescent plasma in low- and middle-income countries by Bloch, Evan M.; Goel, Ruchika; Montemayor, Celina; Cohn, Claudia; Tobian, Aaron A.R. is a Medicine article available to read on EtoBox.

What is Promoting access to COVID-19 convalescent plasma in low- and middle-income countries about?

Low- and middle-income countries (LMICs) remain neglected in the Coronavirus 19 (COVID-19) pandemic. COVID-19 convalescent plasma (CCP) (i.e. plasma collected from individuals after their recovery from COVID-19) has emerged as a leading medical treatment for COVID-19. Studies to date support the safety-and increasingly the efficacy-of CCP to treat COVID-19. This has motivated large-scale procurement and transfusion of CCP, notably in the United States (US), where inventories of CCP have been attained, and government-supported stockpiling of CCP is underway. CCP is a therapy that could be implemented in LMICs. However, systemic and transfusion-specific challenges (e.g. capacity for donor mobilization and collections) impede local procurement of this resource in sufficient volumes to meet clinical demand. This raises the question as to whether there are strategies to facilitate sharing of CCP with LMICs and/or bolstering local capacity for collection to contend with the health crisis. While compelling, there are cost-related, logistical and regulatory barriers to both approaches. For one, there is complexity in diverting national interest (e.g. in the US) away from an epidemic that d

Who reads Promoting access to COVID-19 convalescent plasma in low- and middle-income countries?

Author

Bloch, Evan M.; Goel, Ruchika; Montemayor, Celina; Cohn, Claudia; Tobian, Aaron A.R.

Publisher

Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 1473-0502)

Published

2020

Language

EN

Field

Medicine (Health Sciences)